NICE

Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.

[NICE @NICEComms]

We’ve brought together 25 clinical guidelines and 16 quality standards on women’s health in one place, making evidence easier to find, use and act on

Explore how this work supports the government’s Women’s Health Strategy 👇
https://t.co/8kXzOmWZ9Q

[NICE @NICEComms]

As part of our work to bring NICE guidance together in high priority areas, we’ve added medicines recommendations to our ovarian cancer guideline, giving easy access at the right point in the guideline.

🔗https://t.co/oPGiKMa9DP

#NICEWomensHealth

[NICE @NICEComms]

NHS commissioners in @BlackCountryICS increased uptake in childhood immunisations from 64.4% to 76.8%.

Learn how they utilised a NICE quality standard to communicate with families in their first language.

https://t.co/sgVs778PzK

#WorldImmunisationDay

[NICE @NICEComms]

Our Forward View helps us focus on the areas where we can make the greatest difference.

We’ve refreshed it to reflect our latest guidance and strategic priorities, alongside updates across individual topics areas👇
https://t.co/9k6tDMgpg1

[NICE @NICEComms]

What is NICE’s Forward View?

Our CMO, Dr Adrian Hayter explains how we identify the topics that matter most to the health and care system.

Find out more: https://t.co/j4fpEopt1i

[NICE @NICEComms]

People with an aggressive form of bladder cancer could be set to benefit after we recommended a new treatment, that can be taken before and after surgery, in final draft guidance published today.

Find out more about pembrolizumab: https://t.co/FGpmM0Abgd

[NICE @NICEComms]

We’ve brought together 25 clinical guidelines and 16 quality standards on women’s health in one place, making evidence easier to find, use and act on

Explore how this work supports the government’s Women’s Health Strategy 👇
https://t.co/PuuOglxA5B

[NHS Business Services Authority @NHSBSA]

The Innovation Scorecard has been updated with data to June 2026.

It covers the use of selected @NICEComms recommended medicines across the NHS in England.

It helps NHS teams and researchers understand changes over time and differences between areas.

https://t.co/lVtmPDHV7P

[NICE @NICEComms]

Around 670 people in England could benefit from a treatment for severe, debilitating itching caused by Alagille syndrome.

Maralixibat is taken as a liquid and can help treat cholestatic pruritus, which can severely affect sleep and quality of life.

🔗 https://t.co/JGsnq2khSj

[NICE @NICEComms]

Hundreds of people with a rare inherited genetic disorder that causes high build-ups of fat in the blood are set to benefit after NICE recommended two new treatments in final guidance published today.

Find out more about olezarsen and plozasiran: https://t.co/bT5QoAz3E7

[ICER @icer_review]

The Health Economics Methods Advisory (#HEMA) today released a Draft Report on how HTA bodies can evaluate, present, and communicate uncertainty in #healtheconomic evaluations. #hta #populationhealth

Now accepting public comments until Nov 2. Read more: https://t.co/xNIKRSFWEk

[NICE @NICEComms]

For Clare, who lives with endometriosis, treatment helped her manage severe pain while waiting for surgery.

Read Clare, Lucy and Ruth’s stories, and explore the data: https://t.co/IOyZSKoCeY

[NICE @NICEComms]

NHS use of NICE-recommended tablets for endometriosis and fibroids has more than tripled in a year, from 1.2m to 3.7m tablets.

Behind that rise are women finding new ways to manage painful and debilitating symptoms:
https://t.co/QuDhHtdg5d

#NICEWomensHealth

[NICE @NICEComms]

More than 58,000 people were diagnosed with prostate cancer in England in 2023.

New AI tools could support radiologists interpreting prostate MRI scans, helping them spot possible cancer more accurately.

Read our draft guidance: https://t.co/JyPMrL40jP

[NICE @NICEComms]

Developing a medicine? Get early, joined-up advice from @MHRAgovuk and NICE.

Our integrated scientific advice service is helping companies understand evidence requirements earlier, and prepare for the aligned pathway.

Read how it's working in practice: https://t.co/a2gml5NawL

[NICE @NICEComms]

On #WorldEBHCDay, we're highlighting how AI can support better health and care when it's used safely, transparently and based on robust evidence.

Read how NICE's AI delivery plan will support responsible adoption across the NHS 👇
https://t.co/an3v2WYh6z

[NICE @NICEComms]

From blood-based biomarkers to AI-powered tools, discover how 9 innovations are being tested in the NHS to speed up diagnosis as part of UKRI’s Dementia Challenge: https://t.co/NSm97jVaRW

#Dementia #HealthTech

[NICE @NICEComms]

We've published final guidance recommending trastuzumab deruxtecan as a treatment option for adults with HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments.

Learn more: https://t.co/qrG9hJZcFg

[NICE @NICEComms]

We've recently expanded treatment, including recommending a non-hormonal treatment for moderate to severe hot flushes and night sweats when HRT is not suitable: https://t.co/2o8j1qfRh1

#NICEWomensHealth

[NICE @NICEComms]

This #MenopauseAwarenessDay, explore our guideline on identifying and managing menopause: https://t.co/bGDuqR8Sa5

It supports personalised care and informed treatment choices, including information on treatment options when HRT is not suitable.

#NICEWomensHealth